These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37536846)

  • 1. Translational Epidemiology: Genetic Ancestry in Breast Cancer: What Is the Role of Genetic Ancestry and Socioeconomic Status in Triple-Negative Breast Cancer?
    Goel N; Hernandez A; Merchant N; Rebbeck T
    Adv Surg; 2023 Sep; 57(1):1-14. PubMed ID: 37536846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational Epidemiology: An Integrative Approach to Determine the Interplay Between Genetic Ancestry and Neighborhood Socioeconomic Status on Triple Negative Breast Cancer.
    Goel N; Yadegarynia S; Kwon D; Kesmodel SB; Harbour JW; Kobetz E; Merchant N; Rodriguez DA
    Ann Surg; 2022 Sep; 276(3):430-440. PubMed ID: 35758508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neighborhood and racial influences on triple negative breast cancer: evidence from Northeast Ohio.
    Eom KY; Berg KA; Joseph NE; Runner K; Tarabichi Y; Khiyami A; Perzynski AT; Sossey-Alaoui K
    Breast Cancer Res Treat; 2023 Apr; 198(2):369-381. PubMed ID: 36781520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors.
    Prakash O; Hossain F; Danos D; Lassak A; Scribner R; Miele L
    Front Public Health; 2020; 8():576964. PubMed ID: 33415093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neighborhood Disadvantage, African Genetic Ancestry, Cancer Subtype, and Mortality Among Breast Cancer Survivors.
    Iyer HS; Zeinomar N; Omilian AR; Perlstein M; Davis MB; Omene CO; Pawlish K; Demissie K; Hong CC; Yao S; Ambrosone CB; Bandera EV; Qin B
    JAMA Netw Open; 2023 Aug; 6(8):e2331295. PubMed ID: 37647068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-Negative Breast Cancer, Stem Cells, and African Ancestry.
    Jiagge E; Chitale D; Newman LA
    Am J Pathol; 2018 Feb; 188(2):271-279. PubMed ID: 29137951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer disparities in outcomes; unmasking biological determinants associated with racial and genetic diversity.
    Martini R; Newman L; Davis M
    Clin Exp Metastasis; 2022 Feb; 39(1):7-14. PubMed ID: 33950410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry.
    Brewster AM; Chavez-MacGregor M; Brown P
    Lancet Oncol; 2014 Dec; 15(13):e625-e634. PubMed ID: 25456381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panoptic Overview of Triple-Negative Breast Cancer in Nigeria: Current Challenges and Promising Global Initiatives.
    Wright N; Rida P; Rakha E; Agboola A; Aneja R
    J Glob Oncol; 2018 Jul; 4():1-20. PubMed ID: 30085829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High triple-negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancer.
    Hercules SM; Hercules JC; Ansari A; Date SAJ; Skeete DHA; Smith Connell SP; Pond GR; Daniel JM
    Cancer; 2020 May; 126(10):2217-2224. PubMed ID: 32154924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US Women.
    Sung H; Wiese D; Jatoi I; Jemal A
    JAMA Oncol; 2023 May; 9(5):700-704. PubMed ID: 36862439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities in triple negative breast cancer: toward a causal architecture approach.
    Siegel SD; Brooks MM; Lynch SM; Sims-Mourtada J; Schug ZT; Curriero FC
    Breast Cancer Res; 2022 Jun; 24(1):37. PubMed ID: 35650633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.
    Sturtz LA; Melley J; Mamula K; Shriver CD; Ellsworth RE
    BMC Cancer; 2014 Feb; 14():62. PubMed ID: 24495414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
    Keenan T; Moy B; Mroz EA; Ross K; Niemierko A; Rocco JW; Isakoff S; Ellisen LW; Bardia A
    J Clin Oncol; 2015 Nov; 33(31):3621-7. PubMed ID: 26371147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
    Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
    Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time will tell: Circadian clock dysregulation in triple negative breast cancer.
    Rida P; Syed MI; Aneja R
    Front Biosci (Schol Ed); 2019 Mar; 11(1):178-192. PubMed ID: 30844743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Cancer in San Francisco: Disentangling Disparities at the Neighborhood Level.
    Guan A; Lichtensztajn D; Oh D; Jain J; Tao L; Hiatt RA; Gomez SL; Fejerman L;
    Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):1968-1976. PubMed ID: 31548180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry.
    Jiagge EM; Ulintz PJ; Wong S; McDermott SP; Fossi SI; Suhan TK; Hoenerhoff MJ; Bensenhaver JM; Salem B; Dziubinski M; Oppong JK; Aitpillah F; Ishmael K; Osei-Bonsu E; Adjei E; Baffour A; Aldrich J; Kurdoglu A; Fernando K; Craig DW; Trent JM; Li J; Chitale D; Newman LA; Carpten JD; Wicha MS; Merajver SD
    Breast Cancer Res Treat; 2021 Apr; 186(2):391-401. PubMed ID: 33576900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neighborhood socioeconomic deprivation, tumor subtypes, and causes of death after non-metastatic invasive breast cancer diagnosis: a multilevel competing-risk analysis.
    Lian M; Pérez M; Liu Y; Schootman M; Frisse A; Foldes E; Jeffe DB
    Breast Cancer Res Treat; 2014 Oct; 147(3):661-70. PubMed ID: 25234843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities for improving triple-negative breast cancer outcomes: results of a population-based study.
    Rapiti E; Pinaud K; Chappuis PO; Viassolo V; Ayme A; Neyroud-Caspar I; Usel M; Bouchardy C
    Cancer Med; 2017 Mar; 6(3):526-536. PubMed ID: 28211614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.